Summary
This prediction ended on 11.11.22 with a price of €7.20. The SELL prediction by BiotechBee for Veru Inc performed very well with a performance of -38.34%. BiotechBee has a follow-up prediction for Veru Inc, but this time predicts that Veru Inc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Veru Inc | -3.510% | -3.510% | 1.494% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to BiotechBee what are the pros and cons of Veru Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Veru Inc diskutieren
Sell mit Kursziel 7,0